Microarray Scanners Global Market Report 2024

The microarray scanners market size has grown strongly in recent years. It will grow from $0.89 billion in 2023 to $0.97 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The rise observed in the historical period can be ascribed to the growth of genomic research, expansion in the pharmaceutical industry, activities within academic and research institutes, applications in diagnostics, and the utilization of high-throughput screening.

The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated expansion in the forecast period can be credited to an increasing emphasis on pharmacogenomics, a rising demand for biobanking, heightened attention to infectious disease research, a growing need for diagnostic laboratories, and the expanding application areas of microarrays. Key trends expected in the forecast period encompass a heightened focus on cancer research, ongoing technological innovations, and the pursuit of strategic partnerships.

The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.

The factor poised to fuel the growth of the microarray scanners market in the forthcoming years is the increasing health expenditure. Health expenditure refers to the overall resources, both public and private, invested in health-related products and services within a specific period, typically assessed annually. The augmented spending on health, particularly in the context of microarray scanners, contributes to the advancement and refinement of genomics research, leading to progress in healthcare and personalized therapies. Notably, the Centers for Medicare & Medicaid Services, a US-based government organization responsible for health coverage, reported an anticipated 2.7 percent increase in national health spending to $4.3 trillion in 2021, equating to $12,914 per person and constituting 18.3% of GDP. Consequently, the escalating health expenditure is a driving force behind the microarray scanner market.


The microarray scanners market is witnessing a prominent trend of product innovations, with major companies actively engaged in the development of innovative products to maintain their market standing. An illustration of this trend is Zeiss, a Germany-based optical systems manufacturer, which introduced the ZEISS Axioscan 7 in April 2021 - a next-generation microscopy slide scanner designed for automated digitization of microscopy samples. This new slide scanner features an advanced acquisition engine for higher scan speeds, a broader range of imaging modes offering extended capabilities and flexibility, enhanced fluorescence imaging, and an improved user experience. The ZEISS Axioscan 7 is characterized by consistently high scan rates, user-friendly operation, and customizable options tailored to meet the demands for reliable 24/7 scan performance and superior imaging quality across various applications.

Major players in the microarray scanner market are directing their focus on product innovations, specifically in the development of chromosomal microarray scanners, to better cater to the needs of their existing customer base. Chromosomal microarray scanners are sophisticated laboratory instruments designed for high-throughput DNA sample analysis, with a specific emphasis on detecting chromosomal abnormalities. For example, in August 2023, Thermo Fisher Scientific Inc., a US-based manufacturer of microarray scanners and other analytical instruments, launched the Applied Biosystems CytoScan HD Accel array. This array offers the industry's fastest chromosomal microarray analytical methodology and enhanced coverage, scanning the entire human genome and providing increased coverage in over 5,000 crucial genomic areas. The Applied Biosystems CytoScan HD Accel array contributes valuable insights into chromosomal variations applicable to a wide range of prenatal, postnatal, and cancer research applications.

In January 2022, Illumina Inc., a US-based biotechnology company specializing in microarray scanners, entered into a collaboration with SomaLogic, a US-based clinical diagnostics company. This collaboration aims to expedite next-generation sequencing into Proteomics and initiate a multi-year development effort to integrate SomaLogic's protein target volume with Illumina's sequencing technologies, creating a comprehensive end-to-end NGS workflow solution.

Major companies operating in the microarray scanners market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, GVS S.p.A., Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Affymetrix Inc., Arrayit Corporation, Meridian Bioscience Inc., Montreal Biotech Inc.

North America was the largest region in the microarray scanners market in 2023. The regions covered in the microarray scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.

The microarray scanners market research report is one of a series of new reports that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.


The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.